Biorem (TSXV:BRM) Long-Term Capital Lease Obligation : C$1.02 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Biorem Long-Term Capital Lease Obligation?

Biorem's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$1.02 Mil.

Biorem's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (C$0.21 Mil) to Dec. 2023 (C$1.03 Mil) but then declined from Dec. 2023 (C$1.03 Mil) to Mar. 2024 (C$1.02 Mil).

Biorem's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (C$0.47 Mil) to Dec. 2022 (C$0.31 Mil) but then increased from Dec. 2022 (C$0.31 Mil) to Dec. 2023 (C$1.03 Mil).

Biorem Long-Term Capital Lease Obligation Historical Data

The historical data trend for Biorem's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biorem Long-Term Capital Lease Obligation Chart

Biorem Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.61

0.47

0.31

1.03

Biorem Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.30	0.27	0.21	1.03	1.02

Biorem (TSXV:BRM) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Biorem Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Biorem's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Biorem (TSXV:BRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Biorem Inc (TSXV:BRM) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

BIRMF:USA

Address

7496 Wellington Road 34, RR Number 3, Puslinch, Guelph, ON, CAN, N1H 6H9

Website

https://www.biorem.biz

Biorem Inc is an environmental biotechnology company. It designs, manufactures and distributes a comprehensive line of air emissions control systems used to eliminate odours, volatile organic compounds, and hazardous air pollutants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.

Executives

Brian Herner

Director, Senior Officer

Biorem (TSXV:BRM) Headlines

No Headlines